Iterum Therapeutics PLC

General ticker "ITRM" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $42.4M

Iterum Therapeutics PLC does not follow the US Stock Market performance with the rate: -3.8%.

Estimated limits based on current volatility of 3.9%: low 1.65$, high 1.78$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.32$, 4.29$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.28$, 3.97$]

Financial Metrics affecting the ITRM estimates:

  • Negative: Non-GAAP EPS, $ of -2.97 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -62.67 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85

Similar symbols

Short-term ITRM quotes

Long-term ITRM plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $24.54MM $30.38MM $47.47MM
Operating Income $-24.54MM $-30.38MM $-47.47MM
Non-Operating Income $-66.32MM $-13.75MM $9.71MM
Interest Expense $5.55MM $2.36MM $0.00MM
R&D Expense $10.71MM $17.62MM $39.99MM
Income(Loss) $-90.86MM $-44.13MM $-37.76MM
Taxes $0.70MM $0.30MM $0.61MM
Profit(Loss) $-91.56MM $-44.43MM $-38.37MM
Stockholders Equity $50.23MM $28.00MM $-6.40MM
Inventory $3.13MM $1.85MM $0.00MM
Assets $91.51MM $66.83MM $26.26MM
Operating Cash Flow $-15.84MM $-18.47MM $-39.33MM
Capital expenditure $0.06MM $0.06MM $0.01MM
Investing Cash Flow $-54.59MM $13.96MM $23.34MM
Financing Cash Flow $83.13MM $-1.82MM $1.03MM
Earnings Per Share* $-0.56 $-3.63 $-2.96

* EPS are Split Adjusted, recent splits may be reflected with a delay.